Shares of Biocorrx Inc (OTCMKTS:BICX) dropped 10% during mid-day trading on Thursday . The company traded as low as $3.15 and last traded at $3.15, approximately 2,640 shares changed hands during trading. An increase of 156% from the average daily volume of 1,031 shares. The stock had previously closed at $3.50.
Separately, ValuEngine upgraded shares of Biocorrx from a “hold” rating to a “buy” rating in a report on Thursday, August 1st.
The stock’s fifty day simple moving average is $3.68 and its 200-day simple moving average is $4.59.
BioCorRx, Inc engages in the provision of alcoholism and opioid addiction treatment. It offers treatment philosophy that combines medical intervention and a proprietary cognitive behavioral therapy program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment.
Read More: What is a price target?
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.